FLUDARA

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

FLUDARABINE PHOSPHATE 50 MG/VIAL

Mevcut itibaren:

SANOFI - AVENTIS ISRAEL LTD

ATC kodu:

L01BB05

Farmasötik formu:

POWDER FOR SOLUTION FOR INJ/INF

Uygulama yolu:

I.V

Tarafından üretildi:

GENZYME EUROPE B.V., NETHERLANDS

Terapötik grubu:

FLUDARABINE

Terapötik endikasyonlar:

Palliative treatment of patients with CLL refractory to other therapy. Treatment of less malignant Non-Hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. Fludara is indicated for the initial treatment of patients with B- cell chronic lymphocytic leukaemia (CLL) or after first line therapy, in patients with sufficient bone marrow reserves.

Yetkilendirme tarihi:

2009-02-01